SecBot SecBot
SECBOTREPLAY Home › Report › KYMR

KYMR · Two corporate insiders at Kymera Therapeutics sold shares in the past…

Kymera Therapeutics, Inc. · CLUSTER filed Apr 10, 2026 at 16:45 ET

At the news

NEUTRALIMPACT 3/10

CLUSTER filed Apr 10, 2026 at 16:45 ET

Two corporate insiders at Kymera Therapeutics sold shares in the past week, including Director Booth Bruce selling 4,159 shares for $374,185 and Chief Business Officer Noah Goodman selling 2,000 shares for $174,700. The total open-market sales amount to $549,000, representing 0.0075% of the company's $7.3B market cap. Most transactions were non-cash derivative exercises with no economic impact.

  • Director Booth Bruce sold 4,159 shares for $374,185 on 2026-04-14 and also exercised 10,518 derivative shares (non-cash) across multiple transactions.
  • Chief Business Officer Noah Goodman sold 2,000 shares for $174,700 on 2026-04-10.
  • Total open-market sales in the cluster: $549,000.
  • Total value represents 0.0075% of Kymera's $7.3B market cap.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access